SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-344043
Filing Date
2012-08-08
Accepted
2012-08-08 16:16:00
Documents
3
Period of Report
2012-08-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d393635d8k.htm 8-K 15652
2 PRESS RELEASE d393635dex991.htm EX-99.1 77558
3 GRAPHIC g393635g64l56.jpg GRAPHIC 6165
  Complete submission text file 0001193125-12-344043.txt   103182
Mailing Address 20 ENTERPRISE SUITE 200 ALISO VIEJO CA 92656
Business Address 20 ENTERPRISE SUITE 200 ALISO VIEJO CA 92656 949-389-6700
AVANIR PHARMACEUTICALS, INC. (Filer) CIK: 0000858803 (see all company filings)

IRS No.: 330314804 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-15803 | Film No.: 121017063
SIC: 2834 Pharmaceutical Preparations